LAURA QUESENBERRY: Open Payments
NPI 1528437266 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 10 payments from 6 companies in 2025. Trend: 2023 $747 · 2024 $317 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $82 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
| Alkermes, Inc. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| Lundbeck LLC | 1 | $20 |
| Bausch Health US, LLC | 1 | $19 |
Products named: VRAYLAR, HETLIOZ, REXULTI, ARISTADA, APLENZIN, LYBALVI.
Industry payments across KY — which companies pay providers there.
